The company is recalling eight lots of its 150 mg ranitidine syrup to the consumer level after it found trace amounts of N-nitrosodimethylamine in the heartburn medication. It is the same carcinogen that prompted recalls from several other drugmakers.
The syrup was manufactured by Lannett Company and repackaged by American Health Packaging. It was distributed nationwide to wholesalers for use in hospitals.
American Health Packaging has not received any reports of adverse events related to the recall. The company told distributors to immediately discontinue distribution of the affected lots and to notify subaccounts.
Read the full news release here.
More articles on pharmacy:
Endo CEO to retire
Trump administration sues Gilead
CVS to close 22 ‘underperforming’ stores
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.